It has been suggested that CDK4 provides a selection advantage in well-differentiated liposarcoma and may contribute to transformation as CDK4 negative well-differentiated liposarcoma exhibit more favorable prognostic features (64, 70–72). This evidence concerns the gene CDK4 and liposarcoma.